How a 20-year old asthma drug is boosting food allergy researchnews2026-04-01T15:04:06+00:00April 1st, 2026|Endpoints News|
IO Biotech will file for bankruptcy after failure of cancer vaccine in key trialnews2026-04-01T14:59:54+00:00April 1st, 2026|Endpoints News|
FDA delays decision on Orca Bio cell therapy after filing more manufacturing datanews2026-04-01T12:00:29+00:00April 1st, 2026|Endpoints News|
Oric to advance prostate cancer drug to Phase 3, but combo choice raises doubtsnews2026-04-01T11:10:33+00:00April 1st, 2026|Endpoints News|
Pharma goes on $25.5B, eight-day acquisition spreenews2026-03-31T19:32:28+00:00March 31st, 2026|Endpoints News|
AstraZeneca’s next-gen hopeful for a rare bone condition fails pivotal trialnews2026-03-31T19:21:51+00:00March 31st, 2026|Endpoints News|
FDA identifies eight deaths tied to Amgen’s Tavneosnews2026-03-31T19:13:11+00:00March 31st, 2026|Endpoints News|
Colorado biotech Ambrosia lands $100M for oral GLP-1news2026-03-31T15:40:15+00:00March 31st, 2026|Endpoints News|
Astellas doesn’t pick up AviadoBio’s gene therapy, but nonprofit funding will move it forwardnews2026-03-31T15:33:37+00:00March 31st, 2026|Endpoints News|
